Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P29
Within normal range
vs 3Y Ago
-0.6x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -18.38% |
| Q3 2025 | -2.68% |
| Q2 2025 | 9.42% |
| Q1 2025 | 8.97% |
| Q4 2024 | 12.12% |
| Q3 2024 | -132.38% |
| Q2 2024 | 332.95% |
| Q1 2024 | -9.18% |
| Q4 2023 | -1.10% |
| Q3 2023 | -10.20% |
| Q2 2023 | 13.81% |
| Q1 2023 | -22.44% |
| Q4 2022 | 29.36% |
| Q3 2022 | -1.89% |
| Q2 2022 | -23.79% |
| Q1 2022 | -1.13% |
| Q4 2021 | 3.17% |
| Q3 2021 | -26.67% |
| Q2 2021 | -9.83% |
| Q1 2021 | 18.16% |
| Q4 2020 | -340.19% |
| Q3 2020 | 68.10% |
| Q2 2020 | 7.12% |
| Q1 2020 | -238.24% |
| Q4 2019 | 65.47% |
| Q3 2019 | -7.81% |
| Q2 2019 | -22.00% |
| Q1 2019 | -54.57% |
| Q4 2018 | -55.41% |
| Q3 2018 | 23.80% |
| Q2 2018 | 18.47% |
| Q1 2018 | 0.00% |